TuesdaySep 13, 2022 3:20 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) ASR Patrols Portland Hotel, Augments 24/7 Security

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has deployed another of its proprietary K5 Autonomous Security Robot (“ASR”) to bolster security efforts at a hotel in Portland, Oregon. According to the announcement, the KSCP robot is patrolling the Aloft Hotel area amid security staffing challenges as well as ongoing theft and vandalism problems. The client reached out to Knightscope to arrange for ASR surveillance. As a result, KSCP deployed the robot, which the client dubbed Robby, to provide 24/7 surveillance. Utilizing Knightscope’s technology, Robby informs hotel staff whenever any suspicious activity…

Continue Reading

TuesdaySep 13, 2022 12:39 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Recognized for Strategic M&A Objectives at Benzinga Cannabis Capital Conference

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced its receipt of the Best M&A Deal award at Benzinga’s 2022 Cannabis Capital Conference in Chicago. “We are honored to receive the award for Best M&A Deal at the Benzinga Cannabis Capital Conference, which recognizes our strategic M&A objectives including acquiring products, expertise, expanding distribution, and customers,” said Luis Merchan, chairman and CEO of Flora. To view the full press release, visit https://ibn.fm/vjkvA About Flora Growth Corp. Flora is building a connected, design-led collective of plant-based wellness and lifestyle…

Continue Reading

MondaySep 12, 2022 12:23 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters into $6M Securities Purchase Agreement

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has announced a private placement agreement with two healthcare-focused institutional investors. The agreement calls for the issuance and sale of 691,245 of INM common shares; the shares will be sold at a purchase price of $8.68 per share in a private placement priced according to Nasdaq guidelines. According to the announcement, InMed will also issue unregistered preferred investment options that will allow investors in the offering to purchase more than 1.3 million common shares. The company noted that it anticipates gross proceeds from the placement,…

Continue Reading

MondaySep 12, 2022 10:00 am

TinyGemsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Acquisition of Controlling Stake in Bollinger Motors Featured in Recent Articles

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in recent articles published by InsideEVs and Newsweek that discussed its strategic move to purchase a controlling stake in Bollinger Motors. “EV fresh face Mullen Automotive has purchased a 60% controlling stake in Bollinger Motors for $148.2 million USD cash. It’s the company’s first EV acquisition after having purchased many of its building blocks from other enterprises along the way,” reads the Newsweek publication. The article quotes David Michery, CEO and chairman of Mullen Automotive, stating, “Combining Bollinger’s vehicles with our existing class 1 and class 2 EV…

Continue Reading

FridaySep 09, 2022 11:49 am

TinyGemsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Plans Participation in Key Global Events During September, October

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has released its upcoming event schedule; the company plans to participate in eight events during the coming weeks. The schedule includes key automotive and smart infrastructure events in the United States, Europe and Japan. Those events include AutoSens Brussels, held in Belgium and scheduled for Sept. 12–14; the Next-Generation Sensors Comprehensive Symposium, held virtually Sept. 14–16 and hosted by the Japan Society of Next-Generation Sensor Technology; the North American International Detroit Auto Show, held in Detroit from Sept. 14 to Sept. 25; the ITS World Congress, held…

Continue Reading

FridaySep 09, 2022 11:32 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) CEO Releases Shareholder Statement in Response Bollinger Motors Majority Acquisition

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is updating shareholders about the company’s recent majority acquisition of Bollinger Motors Inc. MULN CEO and chair David Michery released a statement for shareholders providing details about the transaction. U.S.-based Bollinger Motors was founded by Robert Bollinger in 2015 and manufactures all-electric platforms and chassis cabs for commercial vehicles in Classes 3-6. “All cash and stock required to close the Bollinger transaction on Sept. 7, 2022, has been funded or placed in escrow as required by the transaction documents,” said Mullen Automotive CEO and chair David Michery in the press…

Continue Reading

FridaySep 09, 2022 11:21 am

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Expands KCM Relationship to Meet Needs for US/Mexico Cross-Border Traffic

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company based on its custom-developed and AI- and machine learning-powered Fr8App platform, which offers a real-time portal for B2B cross-border shipping and domestic shipping within the United States-Mexico-Canada (“NAFTA”) region. The company today announced the expansion of its relationship with Kimberly Clark de Mexico, S.A.B. de C.V. (“KCM”) to include the Fr8App platform for cross-border logistics for shipments from Mexico to the United States. “Pleased with the level of service and value KCM received from Fr8Fleet and domestic spot services, KCM logistics management chose the Fr8App platform to address their needs for…

Continue Reading

FridaySep 09, 2022 10:06 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Update on Company Objectives and Programs

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting an update on the company’s research/development and commercial activities. According to the update, the company is working to complete enrollment in a phase 2 clinical program in epidermolysis bullosa (‘EB’) by the end of 2023, to advance its R&D efforts on a preclinical drug candidate in ocular disease and to investigate the potential of proprietary cannabinoid analogs in targeting specific diseases. The update included an observation that market demand for INM’s BayMedica naturally occurring cannabinoids is not progressing as anticipated,…

Continue Reading

ThursdaySep 08, 2022 2:34 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Roadshow to Take the Spotlight at Underground Atlanta

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that its Robot Roadshow will land at Underground Atlanta in Georgia from 10 a.m. to 8 p.m. EDT on Sept. 12-13, 2022, and from 10 a.m. to 2 p.m. EDT on Sept. 14, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Robot Roadshow (www.knightscope.com/roadshow) has made 52 landings in 22 states and Washington, D.C., to date. Knightscope’s crime-fighting robots…

Continue Reading

ThursdaySep 08, 2022 1:39 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) on Leading Edge of Psilocybin Research

Cybin (NYSE American: CYBN) (NEO: CYBN) is a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions. The company is on the leading edge of a transformation that has seen the status of psilocybin evolve as a result of mounting public acceptance and growing evidence that the substance delivers remarkable health benefits. “After a flurry of research in the 1950s and 1960s, psilocybin and all other psychedelics were abruptly banned, partly in response to their embrace by the counterculture. Following the 1971 United Nations Convention on Psychotropic Substances, psilocybin was classed in the U.S.…

Continue Reading

Contact us: (512) 354-7000